The mammalian target of rapamycin, a drug originally developed to prevent immunosuppression, is mTOR. mTOR is one of the most critical proteins in the control of cell proliferation, including cancer. For decades scientists have been researching mTOR to gain a thorough understanding of exactly how it regulates such an essential cell function that impacts metabolism, growth, protein and organelle recycling (autophagy), proliferation, and survival. Now, a … Continue reading Study identifies mTOR pathway that controls cancer proliferation via nutrients.